Musso, L.; Maltese, C.; Beretta, G.; Patelli, I.; Raffa, S.; Piccardo, A.; Fiz, F.; Vera, L.; Albertelli, M.; Minuto, M.;
et al. Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation. Pharmaceuticals 2025, 18, 443.
https://doi.org/10.3390/ph18040443
AMA Style
Musso L, Maltese C, Beretta G, Patelli I, Raffa S, Piccardo A, Fiz F, Vera L, Albertelli M, Minuto M,
et al. Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation. Pharmaceuticals. 2025; 18(4):443.
https://doi.org/10.3390/ph18040443
Chicago/Turabian Style
Musso, Laura, Cristina Maltese, Giulio Beretta, Ilaria Patelli, Stefano Raffa, Arnoldo Piccardo, Francesco Fiz, Lara Vera, Manuela Albertelli, Michele Minuto,
and et al. 2025. "Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation" Pharmaceuticals 18, no. 4: 443.
https://doi.org/10.3390/ph18040443
APA Style
Musso, L., Maltese, C., Beretta, G., Patelli, I., Raffa, S., Piccardo, A., Fiz, F., Vera, L., Albertelli, M., Minuto, M., Ferone, D., Bagnasco, M., & Gay, S.
(2025). Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation. Pharmaceuticals, 18(4), 443.
https://doi.org/10.3390/ph18040443
